25 XP   0   0   10

Jiangsu Lianhuan Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Jiangsu Lianhuan Pharmaceutical Co Ltd together

PenkeI guess you are interested in Jiangsu Lianhuan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Jiangsu Lianhuan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Jiangsu Lianhuan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Lianhuan Pharmaceutical Co Ltd.

Quick analysis of Jiangsu Lianhuan Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Jiangsu Lianhuan Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.32
Expected worth in 1 year
¥5.71
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥0.57
Return On Investment
6.7%

For what price can you sell your share?

Current Price per Share
¥8.57
Expected price per share
¥6.71 - ¥9.65
How sure are you?
50%

1. Valuation of Jiangsu Lianhuan Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.57

Intrinsic Value Per Share

¥4.18 - ¥25.74

Total Value Per Share

¥9.50 - ¥31.06

2. Growth of Jiangsu Lianhuan Pharmaceutical Co Ltd (5 min.)




Is Jiangsu Lianhuan Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$209.6m$187.7m$15m7.4%

How much money is Jiangsu Lianhuan Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4.6m$4.8m-$219.8k-4.7%
Net Profit Margin6.2%7.2%--

How much money comes from the company's main activities?

3. Financial Health of Jiangsu Lianhuan Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Jiangsu Lianhuan Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Jiangsu Lianhuan Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangsu Lianhuan Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Jiangsu Lianhuan Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Jiangsu Lianhuan Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Lianhuan Pharmaceutical Co Ltd is ¥8.57. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Lianhuan Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Lianhuan Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.32. Based on the TTM, the Book Value Change Per Share is ¥0.10 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Lianhuan Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.3%0.020.2%0.020.2%0.010.2%0.010.1%
Usd Book Value Change Per Share0.030.3%0.010.2%0.020.2%0.010.2%0.010.2%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.030.4%0.020.2%0.020.3%0.020.2%0.020.2%
Usd Price Per Share1.54-1.43-1.33-1.30-1.66-
Price to Earnings Ratio17.22-22.66-21.18-25.03-51.07-
Price-to-Total Gains Ratio48.02-84.60-84.40-80.06-134.89-
Price to Book Ratio2.10-2.02-2.03-2.20-4.30-
Price-to-Total Gains Ratio48.02-84.60-84.40-80.06-134.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.184374
Number of shares844
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.02
Gains per Quarter (844 shares)16.6417.56
Gains per Year (844 shares)66.5570.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1214657205060
2429112440100130
36213719160150200
48318325881200270
5104229325101250340
6125274392121300410
7146320459141351480
8167366526161401550
9187411593181451620
10208457660202501690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%82.00.01.098.8%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%37.03.00.092.5%75.08.00.090.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%80.00.03.096.4%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%80.03.00.096.4%

Fundamentals of Jiangsu Lianhuan Pharmaceutical Co Ltd

About Jiangsu Lianhuan Pharmaceutical Co Ltd

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals, preparations, and API products in China. The company offers clopidogrel bisulfate tablets used to prevent atherothrombotic events; azithromycin tablets for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms; milrinone injection for short-term intravenous therapy in patients with acute compensated heart failure; and dapoxetine hydrochloride tablets for the treatment of premature ejaculation in men, as well as epulet, ebastine, felodipine, and terfenadine tablets, drotaverine hydrochloride injection, and danazol suppository. It also offers preparation products, which covers urinary system, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics. In addition, the company engages in the wholesale of chemical raw materials and pharmaceuticals, as well as provides technological transfers and technical consultation services. It exports its products to Southeast Asia, North America, South America, Europe, New Zealand, Australia, and other countries. The company was founded in 1999 and is headquartered in Yangzhou, China.

Fundamental data was last updated by Penke on 2024-04-17 08:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Jiangsu Lianhuan Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Jiangsu Lianhuan Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.7% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 6.7%. The company is making a profit. +1
  • The TTM is 6.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.7%TTM6.2%+0.5%
TTM6.2%YOY7.2%-1.0%
TTM6.2%5Y6.9%-0.7%
5Y6.9%10Y7.7%-0.8%
1.1.2. Return on Assets

Shows how efficient Jiangsu Lianhuan Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Assets means that Jiangsu Lianhuan Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.2%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.2%+0.4%
TTM1.2%YOY1.4%-0.2%
TTM1.2%5Y1.3%-0.1%
5Y1.3%10Y1.4%-0.1%
1.1.3. Return on Equity

Shows how efficient Jiangsu Lianhuan Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.4% Return on Equity means Jiangsu Lianhuan Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM2.6%+0.8%
TTM2.6%YOY2.9%-0.3%
TTM2.6%5Y2.5%+0.0%
5Y2.5%10Y2.3%+0.2%

1.2. Operating Efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Jiangsu Lianhuan Pharmaceutical Co Ltd is operating .

  • Measures how much profit Jiangsu Lianhuan Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.5%-4.5%
TTM4.5%YOY8.7%-4.2%
TTM4.5%5Y8.8%-4.3%
5Y8.8%10Y5.0%+3.8%
1.2.2. Operating Ratio

Measures how efficient Jiangsu Lianhuan Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.41 means that the operating costs are ¥1.41 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 1.406. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.429. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.406TTM1.429-0.023
TTM1.429YOY1.355+0.073
TTM1.4295Y1.355+0.073
5Y1.35510Y0.928+0.428

1.3. Liquidity of Jiangsu Lianhuan Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Jiangsu Lianhuan Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.09 means the company has ¥1.09 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 1.086. The company is just able to pay all its short-term debts.
  • The TTM is 1.080. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.086TTM1.080+0.005
TTM1.080YOY1.128-0.048
TTM1.0805Y1.266-0.185
5Y1.26610Y0.845+0.420
1.3.2. Quick Ratio

Measures if Jiangsu Lianhuan Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.39 means the company can pay off ¥0.39 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 0.392. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.430. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.392TTM0.430-0.038
TTM0.430YOY0.511-0.081
TTM0.4305Y0.524-0.094
5Y0.52410Y0.838-0.314

1.4. Solvency of Jiangsu Lianhuan Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Lianhuan Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Jiangsu Lianhuan Pharmaceutical Co Ltd assets are financed with 46.9% credit (debt) and the remaining percentage (100% - 46.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 0.469. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.472. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.469TTM0.472-0.004
TTM0.472YOY0.472+0.001
TTM0.4725Y0.432+0.040
5Y0.43210Y0.346+0.086
1.4.2. Debt to Equity Ratio

Measures if Jiangsu Lianhuan Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 98.8% means that company has ¥0.99 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The MRQ is 0.988. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.002. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.988TTM1.002-0.014
TTM1.002YOY0.997+0.005
TTM1.0025Y0.849+0.153
5Y0.84910Y0.606+0.243

2. Market Valuation of Jiangsu Lianhuan Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Lianhuan Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangsu Lianhuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 17.22 means the investor is paying ¥17.22 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The EOD is 13.247. Based on the earnings, the company is underpriced. +1
  • The MRQ is 17.220. Based on the earnings, the company is fair priced.
  • The TTM is 22.664. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.247MRQ17.220-3.973
MRQ17.220TTM22.664-5.444
TTM22.664YOY21.178+1.485
TTM22.6645Y25.027-2.363
5Y25.02710Y51.074-26.047
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The EOD is 5.194. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.752. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -9.633. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.194MRQ6.752-1.558
MRQ6.752TTM-9.633+16.385
TTM-9.633YOY-12.766+3.133
TTM-9.6335Y-4.356-5.277
5Y-4.35610Y-17.496+13.140
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Jiangsu Lianhuan Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Lianhuan Pharmaceutical Co Ltd:

  • The EOD is 1.612. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.096. Based on the equity, the company is underpriced. +1
  • The TTM is 2.021. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.612MRQ2.096-0.484
MRQ2.096TTM2.021+0.075
TTM2.021YOY2.033-0.012
TTM2.0215Y2.203-0.183
5Y2.20310Y4.296-2.093
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Jiangsu Lianhuan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2070.098+112%0.119+74%0.107+93%0.098+112%
Book Value Per Share--5.3155.119+4%4.727+12%4.300+24%3.430+55%
Current Ratio--1.0861.080+0%1.128-4%1.266-14%0.845+28%
Debt To Asset Ratio--0.4690.472-1%0.472-1%0.432+8%0.346+35%
Debt To Equity Ratio--0.9881.002-1%0.997-1%0.849+16%0.606+63%
Dividend Per Share--0.0250.045-45%0.050-50%0.043-43%0.043-42%
Eps--0.1620.118+37%0.113+43%0.098+65%0.075+115%
Free Cash Flow Per Share--0.412-0.034+108%-0.071+117%-0.088+121%-0.064+116%
Free Cash Flow To Equity Per Share--0.412-0.057+114%-0.004+101%-0.039+109%0.045+823%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--25.740--------
Intrinsic Value_10Y_min--4.180--------
Intrinsic Value_1Y_max--0.224--------
Intrinsic Value_1Y_min---0.142--------
Intrinsic Value_3Y_max--2.468--------
Intrinsic Value_3Y_min--0.056--------
Intrinsic Value_5Y_max--6.876--------
Intrinsic Value_5Y_min--0.783--------
Market Cap2446357920.000-30%3179982847.8002966534871.575+7%2756470036.505+15%2711894582.966+17%3449614418.143-8%
Net Profit Margin--0.0670.062+8%0.072-8%0.069-3%0.077-13%
Operating Margin---0.045-100%0.087-100%0.088-100%0.050-100%
Operating Ratio--1.4061.429-2%1.355+4%1.355+4%0.928+52%
Pb Ratio1.612-30%2.0962.021+4%2.033+3%2.203-5%4.296-51%
Pe Ratio13.247-30%17.22022.664-24%21.178-19%25.027-31%51.074-66%
Price Per Share8.570-30%11.14010.348+8%9.593+16%9.390+19%12.014-7%
Price To Free Cash Flow Ratio5.194-30%6.752-9.633+243%-12.766+289%-4.356+165%-17.496+359%
Price To Total Gains Ratio36.943-30%48.02284.604-43%84.401-43%80.064-40%134.892-64%
Quick Ratio--0.3920.430-9%0.511-23%0.524-25%0.838-53%
Return On Assets--0.0160.012+34%0.014+18%0.013+24%0.014+13%
Return On Equity--0.0340.026+33%0.029+18%0.025+35%0.023+47%
Total Gains Per Share--0.2320.143+63%0.169+38%0.151+54%0.140+65%
Usd Book Value--209692278.388202815056.921+3%187727187.488+12%171616866.589+22%136577154.964+54%
Usd Book Value Change Per Share--0.0290.014+112%0.016+74%0.015+93%0.013+112%
Usd Book Value Per Share--0.7350.707+4%0.653+12%0.594+24%0.474+55%
Usd Dividend Per Share--0.0030.006-45%0.007-50%0.006-43%0.006-42%
Usd Eps--0.0220.016+37%0.016+43%0.014+65%0.010+115%
Usd Free Cash Flow--16271461.821-1380745.326+108%-2813330.008+117%-3540515.525+122%-2337323.824+114%
Usd Free Cash Flow Per Share--0.057-0.005+108%-0.010+117%-0.012+121%-0.009+116%
Usd Free Cash Flow To Equity Per Share--0.057-0.008+114%-0.001+101%-0.005+109%0.006+823%
Usd Market Cap338086664.544-30%439473629.566409975119.252+7%380944159.045+15%374783831.366+17%476736712.587-8%
Usd Price Per Share1.184-30%1.5401.430+8%1.326+16%1.298+19%1.660-7%
Usd Profit--6380239.7604664544.362+37%4884351.745+31%3993639.976+60%3036446.476+110%
Usd Revenue--95454049.64475115165.556+27%67550666.806+41%58399483.081+63%41721766.377+129%
Usd Total Gains Per Share--0.0320.020+63%0.023+38%0.021+54%0.019+65%
 EOD+4 -4MRQTTM+27 -8YOY+24 -115Y+23 -1210Y+22 -13

3.2. Fundamental Score

Let's check the fundamental score of Jiangsu Lianhuan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.247
Price to Book Ratio (EOD)Between0-11.612
Net Profit Margin (MRQ)Greater than00.067
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.392
Current Ratio (MRQ)Greater than11.086
Debt to Asset Ratio (MRQ)Less than10.469
Debt to Equity Ratio (MRQ)Less than10.988
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.016
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Jiangsu Lianhuan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.548
Ma 20Greater thanMa 509.038
Ma 50Greater thanMa 1008.803
Ma 100Greater thanMa 20010.038
OpenGreater thanClose8.190
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,855,702
Total Liabilities1,338,392
Total Stockholder Equity1,354,189
 As reported
Total Liabilities 1,338,392
Total Stockholder Equity+ 1,354,189
Total Assets = 2,855,702

Assets

Total Assets2,855,702
Total Current Assets1,353,403
Long-term Assets1,502,299
Total Current Assets
Cash And Cash Equivalents 281,380
Net Receivables 488,616
Inventory 315,448
Other Current Assets 20,902
Total Current Assets  (as reported)1,353,403
Total Current Assets  (calculated)1,106,345
+/- 247,058
Long-term Assets
Property Plant Equipment 1,284,837
Goodwill 21,072
Intangible Assets 138,972
Long-term Assets Other 11,489
Long-term Assets  (as reported)1,502,299
Long-term Assets  (calculated)1,456,370
+/- 45,929

Liabilities & Shareholders' Equity

Total Current Liabilities1,246,521
Long-term Liabilities91,871
Total Stockholder Equity1,354,189
Total Current Liabilities
Short Long Term Debt 591,762
Accounts payable 263,382
Other Current Liabilities 146,897
Total Current Liabilities  (as reported)1,246,521
Total Current Liabilities  (calculated)1,002,042
+/- 244,480
Long-term Liabilities
Long term Debt 79,000
Capital Lease Obligations Min Short Term Debt3,912
Long-term Liabilities  (as reported)91,871
Long-term Liabilities  (calculated)82,912
+/- 8,958
Total Stockholder Equity
Retained Earnings 712,265
Total Stockholder Equity (as reported)1,354,189
Total Stockholder Equity (calculated)712,265
+/- 641,924
Other
Capital Stock285,456
Common Stock Shares Outstanding 285,456
Net Debt 389,382
Net Invested Capital 2,024,951
Net Working Capital 106,882
Property Plant and Equipment Gross 1,421,275



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-06-302003-03-312002-12-312001-12-312000-12-31
> Total Assets 
103,668
115,664
126,280
277,246
270,859
293,209
300,809
304,074
321,232
312,051
302,783
308,336
304,337
305,413
330,085
333,793
337,214
335,839
345,642
342,308
348,867
357,657
344,645
347,884
356,333
359,664
354,441
362,626
366,212
383,362
370,269
375,240
380,331
401,080
401,928
401,517
413,761
418,522
420,293
427,255
434,378
443,209
448,575
625,483
638,088
649,475
649,774
674,499
658,661
658,959
662,817
952,187
959,202
1,000,537
992,502
1,020,753
1,033,800
1,066,284
1,034,169
1,049,344
1,078,910
1,164,477
1,180,209
1,166,796
1,212,865
1,420,035
1,430,710
1,501,939
1,558,789
1,889,598
1,907,947
1,880,549
1,934,053
2,049,066
2,084,803
2,167,394
2,206,399
2,354,796
2,479,027
2,533,133
2,561,270
2,714,939
2,706,945
2,756,153
2,805,468
2,855,702
2,855,7022,805,4682,756,1532,706,9452,714,9392,561,2702,533,1332,479,0272,354,7962,206,3992,167,3942,084,8032,049,0661,934,0531,880,5491,907,9471,889,5981,558,7891,501,9391,430,7101,420,0351,212,8651,166,7961,180,2091,164,4771,078,9101,049,3441,034,1691,066,2841,033,8001,020,753992,5021,000,537959,202952,187662,817658,959658,661674,499649,774649,475638,088625,483448,575443,209434,378427,255420,293418,522413,761401,517401,928401,080380,331375,240370,269383,362366,212362,626354,441359,664356,333347,884344,645357,657348,867342,308345,642335,839337,214333,793330,085305,413304,337308,336302,783312,051321,232304,074300,809293,209270,859277,246126,280115,664103,668
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
789,396
786,987
880,101
870,249
869,587
859,586
1,040,892
993,950
955,887
991,503
1,063,008
994,831
1,073,873
1,100,752
1,202,350
1,261,008
1,279,471
1,294,904
1,368,558
1,329,769
1,342,529
1,339,906
1,353,403
1,353,4031,339,9061,342,5291,329,7691,368,5581,294,9041,279,4711,261,0081,202,3501,100,7521,073,873994,8311,063,008991,503955,887993,9501,040,892859,586869,587870,249880,101786,987789,396000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
376,867
321,513
298,163
259,764
219,575
203,916
288,468
237,970
262,924
285,120
241,829
175,791
175,009
240,718
330,694
277,317
248,261
224,422
330,647
253,867
210,639
204,433
281,380
281,380204,433210,639253,867330,647224,422248,261277,317330,694240,718175,009175,791241,829285,120262,924237,970288,468203,916219,575259,764298,163321,513376,867000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69
44
44
45
35
33
35
38
55
64
81
0
0
0
0
0
0
0
0
0
0000000008164553835333545444469000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
37,251
36,480
40,478
49,075
50,452
62,888
64,721
71,427
84,040
74,955
78,542
78,761
85,088
77,380
80,497
83,100
92,671
79,794
83,774
95,101
90,684
87,072
99,008
106,471
105,812
98,275
97,379
108,469
117,705
111,905
111,051
117,311
129,955
130,071
143,097
149,934
154,189
144,295
150,372
158,640
168,714
161,945
164,014
222,432
233,318
213,466
236,313
256,949
258,251
226,022
250,232
243,486
247,452
249,766
231,778
230,427
237,113
245,895
233,012
237,623
263,992
310,737
273,668
300,540
328,987
367,846
209,322
228,030
239,855
482,544
477,022
456,711
462,781
522,820
493,306
525,813
490,098
530,077
582,959
613,365
568,068
590,690
547,438
617,066
479,749
488,616
488,616479,749617,066547,438590,690568,068613,365582,959530,077490,098525,813493,306522,820462,781456,711477,022482,544239,855228,030209,322367,846328,987300,540273,668310,737263,992237,623233,012245,895237,113230,427231,778249,766247,452243,486250,232226,022258,251256,949236,313213,466233,318222,432164,014161,945168,714158,640150,372144,295154,189149,934143,097130,071129,955117,311111,051111,905117,705108,46997,37998,275105,812106,47199,00887,07290,68495,10183,77479,79492,67183,10080,49777,38085,08878,76178,54274,95584,04071,42764,72162,88850,45249,07540,47836,48037,251
       Other Current Assets 
2,798
4,979
2,209
7,173
11,358
13,909
20,342
21,401
19,158
16,729
17,131
19,818
21,005
15,621
21,839
20,744
16,213
17,696
16,104
15,004
20,834
17,666
10,742
10,256
14,095
10,697
13,258
15,992
17,884
13,496
9,313
8,286
7,170
15,973
11,518
12,805
18,061
12,906
12,699
10,515
15,286
18,479
17,936
27,555
19,978
27,429
13,652
35,223
21,491
21,782
11,299
32,608
16,177
11,876
15,342
35,460
40,168
52,093
52,894
15,474
14,052
20,477
13,229
11,687
26,774
57,226
8,167
5,683
2,547
32,396
60,110
31,941
44,120
103,349
124,080
164,419
171,752
138,989
173,904
173,205
250,465
167,830
225,129
188,596
17,611
20,902
20,90217,611188,596225,129167,830250,465173,205173,904138,989171,752164,419124,080103,34944,12031,94160,11032,3962,5475,6838,16757,22626,77411,68713,22920,47714,05215,47452,89452,09340,16835,46015,34211,87616,17732,60811,29921,78221,49135,22313,65227,42919,97827,55517,93618,47915,28610,51512,69912,90618,06112,80511,51815,9737,1708,2869,31313,49617,88415,99213,25810,69714,09510,25610,74217,66620,83415,00416,10417,69616,21320,74421,83915,62121,00519,81817,13116,72919,15821,40120,34213,90911,3587,1732,2094,9792,798
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
560,461
632,353
699,203
848,706
913,997
924,662
942,549
986,058
1,089,971
1,093,521
1,105,647
1,152,446
1,218,019
1,253,663
1,266,366
1,346,381
1,377,175
1,413,624
1,465,562
1,502,299
1,502,2991,465,5621,413,6241,377,1751,346,3811,266,3661,253,6631,218,0191,152,4461,105,6471,093,5211,089,971986,058942,549924,662913,997848,706699,203632,353560,461000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
25,289
23,022
26,497
26,684
26,945
33,967
33,716
33,976
35,233
35,783
36,899
37,969
40,101
44,846
46,439
51,254
59,984
70,192
72,628
77,433
75,904
76,245
88,854
89,021
88,520
87,383
86,825
86,442
85,588
92,405
91,375
92,559
93,837
94,925
93,521
92,985
94,717
105,033
103,171
103,185
105,636
105,678
105,895
164,101
170,647
175,548
177,672
178,202
178,823
184,141
179,056
181,268
187,648
186,047
185,489
183,303
186,003
196,586
194,205
203,913
210,983
231,075
280,531
283,472
324,436
435,801
455,189
533,392
597,281
690,437
759,304
726,003
803,839
713,427
919,440
796,725
930,262
973,928
1,032,412
945,120
1,085,285
1,142,817
1,164,429
1,196,128
1,221,177
1,284,837
1,284,8371,221,1771,196,1281,164,4291,142,8171,085,285945,1201,032,412973,928930,262796,725919,440713,427803,839726,003759,304690,437597,281533,392455,189435,801324,436283,472280,531231,075210,983203,913194,205196,586186,003183,303185,489186,047187,648181,268179,056184,141178,823178,202177,672175,548170,647164,101105,895105,678105,636103,185103,171105,03394,71792,98593,52194,92593,83792,55991,37592,40585,58886,44286,82587,38388,52089,02188,85476,24575,90477,43372,62870,19259,98451,25446,43944,84640,10137,96936,89935,78335,23333,97633,71633,96726,94526,68426,49723,02225,289
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,072
21,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,07221,072000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,844
5,529
5,586
5,448
5,356
5,180
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000005,1805,3565,4485,5865,5295,844000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
10,670
10,088
9,096
8,788
8,480
8,189
7,796
7,488
7,180
7,112
6,804
8,951
6,188
6,120
5,812
7,959
5,202
5,128
10,182
4,512
9,525
4,136
15,990
15,378
14,766
14,292
13,680
13,068
12,462
12,084
11,472
10,860
10,248
9,875
9,263
8,678
8,088
7,500
7,196
6,892
6,589
6,284
5,980
5,676
5,372
6,411
6,107
5,788
5,499
5,166
4,423
4,629
9,040
9,053
8,759
64,119
8,151
42,676
42,216
41,691
40,177
40,185
39,693
39,504
39,012
38,607
49,651
15,608
51,476
91,103
91,417
94,665
95,136
102,571
103,619
110,573
111,955
118,893
118,629
117,937
116,592
126,190
125,450
131,250
131,781
138,972
138,972131,781131,250125,450126,190116,592117,937118,629118,893111,955110,573103,619102,57195,13694,66591,41791,10351,47615,60849,65138,60739,01239,50439,69340,18540,17741,69142,21642,6768,15164,1198,7599,0539,0404,6294,4235,1665,4995,7886,1076,4115,3725,6765,9806,2846,5896,8927,1967,5008,0888,6789,2639,87510,24810,86011,47212,08412,46213,06813,68014,29214,76615,37815,9904,1369,5254,51210,1825,1285,2027,9595,8126,1206,1888,9516,8047,1127,1807,4887,7968,1898,4808,7889,09610,08810,670
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,933
31,061
32,830
28,469
26,089
9,562
813,783
30,547
29,936
-84,501
23,732
-103,759
27,744
18,829
25,267
27,297
37,580
37,381
57,120
11,489
11,48957,12037,38137,58027,29725,26718,82927,744-103,75923,732-84,50129,93630,547813,7839,56226,08928,46932,83031,06138,933000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
48,509
46,180
41,021
40,302
29,596
46,993
51,727
51,816
68,609
61,635
50,398
56,580
49,372
49,439
73,164
78,344
79,972
76,643
81,008
78,618
82,856
87,685
71,535
70,917
76,158
77,979
69,125
76,867
75,569
89,473
72,584
76,133
75,413
92,131
88,801
87,103
92,646
90,909
86,855
92,218
92,563
92,787
91,678
238,252
223,856
247,363
237,694
262,145
234,102
224,706
230,495
204,033
196,541
225,662
205,170
226,634
223,353
239,031
193,907
206,293
221,118
286,248
286,131
271,266
294,546
473,428
467,248
535,457
559,482
805,571
799,898
766,038
779,270
867,054
872,132
952,073
955,619
1,073,870
1,155,889
1,204,466
1,193,313
1,301,207
1,257,291
1,319,689
1,338,705
1,338,392
1,338,3921,338,7051,319,6891,257,2911,301,2071,193,3131,204,4661,155,8891,073,870955,619952,073872,132867,054779,270766,038799,898805,571559,482535,457467,248473,428294,546271,266286,131286,248221,118206,293193,907239,031223,353226,634205,170225,662196,541204,033230,495224,706234,102262,145237,694247,363223,856238,25291,67892,78792,56392,21886,85590,90992,64687,10388,80192,13175,41376,13372,58489,47375,56976,86769,12577,97976,15870,91771,53587,68582,85678,61881,00876,64379,97278,34473,16449,43949,37256,58050,39861,63568,60951,81651,72746,99329,59640,30241,02146,18048,509
   > Total Current Liabilities 
47,909
43,960
38,501
37,732
27,026
45,672
50,407
50,506
67,289
60,315
49,078
55,260
48,052
48,119
60,843
68,024
72,652
37,643
38,172
37,617
39,840
54,667
44,518
70,917
76,158
77,980
69,124
76,844
75,555
89,473
72,584
76,133
75,413
92,131
88,801
87,103
92,646
90,909
86,855
92,218
92,563
92,787
91,678
238,252
223,856
247,363
237,694
262,145
234,102
224,706
230,495
204,033
196,541
225,662
185,170
206,635
203,353
219,021
173,897
186,283
201,108
266,218
241,101
226,236
249,516
473,398
467,218
535,427
559,452
758,541
752,868
718,402
731,634
823,011
825,886
905,058
907,179
1,017,331
1,099,280
1,148,440
1,125,825
1,243,829
1,200,125
1,261,731
1,259,788
1,246,521
1,246,5211,259,7881,261,7311,200,1251,243,8291,125,8251,148,4401,099,2801,017,331907,179905,058825,886823,011731,634718,402752,868758,541559,452535,427467,218473,398249,516226,236241,101266,218201,108186,283173,897219,021203,353206,635185,170225,662196,541204,033230,495224,706234,102262,145237,694247,363223,856238,25291,67892,78792,56392,21886,85590,90992,64687,10388,80192,13175,41376,13372,58489,47375,55576,84469,12477,98076,15870,91744,51854,66739,84037,61738,17237,64372,65268,02460,84348,11948,05255,26049,07860,31567,28950,50650,40745,67227,02637,73238,50143,96047,909
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146,900
193,900
199,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000199,000193,900146,900000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146,900
193,900
199,000
278,885
337,885
287,385
297,385
287,366
342,366
442,366
447,366
454,073
524,573
534,573
535,108
538,300
535,785
541,924
562,090
591,762
591,762562,090541,924535,785538,300535,108534,573524,573454,073447,366442,366342,366287,366297,385287,385337,885278,885199,000193,900146,900000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
10,433
5,112
5,599
3,267
5,700
17,982
24,266
27,559
27,927
23,337
20,904
16,340
13,159
18,933
12,843
15,193
17,439
18,454
11,691
13,579
18,696
24,627
21,048
22,084
18,270
28,146
17,463
18,426
16,301
33,312
17,161
18,373
25,333
33,801
29,293
30,310
29,294
33,814
26,422
25,940
27,632
29,523
29,601
79,355
63,576
63,830
49,235
67,967
52,176
72,487
54,551
51,884
53,890
71,407
39,416
58,066
59,956
64,756
36,280
41,441
64,329
72,346
77,534
54,970
67,606
159,464
139,082
128,957
152,690
219,730
186,000
189,148
183,073
233,912
197,610
191,072
158,545
227,957
236,033
227,248
195,391
248,107
250,762
251,699
237,969
263,382
263,382237,969251,699250,762248,107195,391227,248236,033227,957158,545191,072197,610233,912183,073189,148186,000219,730152,690128,957139,082159,46467,60654,97077,53472,34664,32941,44136,28064,75659,95658,06639,41671,40753,89051,88454,55172,48752,17667,96749,23563,83063,57679,35529,60129,52327,63225,94026,42233,81429,29430,31029,29333,80125,33318,37317,16133,31216,30118,42617,46328,14618,27022,08421,04824,62718,69613,57911,69118,45417,43915,19312,84318,93313,15916,34020,90423,33727,92727,55924,26617,9825,7003,2675,5995,11210,433
       Other Current Liabilities 
11,176
14,148
9,202
10,765
8,686
16,690
10,141
13,947
22,362
18,978
19,174
25,920
21,893
15,186
13,000
17,831
20,213
16,189
15,981
21,538
18,644
27,540
20,970
19,633
23,688
15,634
17,461
23,418
22,254
19,161
18,423
20,760
22,080
20,330
20,508
20,793
24,352
18,095
21,433
27,278
24,931
23,264
22,077
48,897
51,280
41,533
46,959
50,678
43,426
43,720
37,444
46,649
47,152
58,755
50,254
53,068
47,897
58,765
45,118
56,343
51,278
107,372
84,066
50,101
77,741
162,020
20,362
18,313
25,142
195,134
201,795
212,182
237,733
191,188
274,434
211,809
286,695
314,463
326,205
254,971
361,707
281,551
355,574
330,683
170,159
146,897
146,897170,159330,683355,574281,551361,707254,971326,205314,463286,695211,809274,434191,188237,733212,182201,795195,13425,14218,31320,362162,02077,74150,10184,066107,37251,27856,34345,11858,76547,89753,06850,25458,75547,15246,64937,44443,72043,42650,67846,95941,53351,28048,89722,07723,26424,93127,27821,43318,09524,35220,79320,50820,33022,08020,76018,42319,16122,25423,41817,46115,63423,68819,63320,97027,54018,64421,53815,98116,18920,21317,83113,00015,18621,89325,92019,17418,97822,36213,94710,14116,6908,68610,7659,20214,14811,176
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
30
30
47,030
47,030
47,636
47,636
44,043
46,246
47,015
48,440
56,539
56,609
56,026
67,489
57,378
57,165
57,959
78,918
91,871
91,87178,91857,95957,16557,37867,48956,02656,60956,53948,44047,01546,24644,04347,63647,63647,03047,030303030000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-146,900
-193,900
-199,000
0
0
0
0
0
2,203
2,085
1,966
0
0
0
0
0
0
0
0
3,912
3,912000000001,9662,0852,20300000-199,000-193,900-146,900000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,000
47,000
45,500
43
0
43
0
43
0
368
0
0
0
0
0
0
0
000000036804304304345,50047,00047,000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,881
8,721
10,922
11,536
12,746
14,347
20,971
21,628
26,613
27,416
35,650
37,401
42,958
44,171
45,918
46,008
36,882
28,945
41,487
41,360
43,888
0
0
0043,88841,36041,48728,94536,88246,00845,91844,17142,95837,40135,65027,41626,61321,62820,97114,34712,74611,53610,9228,7217,881000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
55,159
69,484
85,260
236,944
241,263
245,504
248,247
251,376
251,733
249,762
251,755
251,169
252,725
253,933
255,000
253,475
255,331
257,351
262,700
261,917
264,221
267,121
270,288
274,124
277,311
280,223
283,930
284,335
289,179
293,138
297,094
298,746
304,478
308,519
312,757
314,002
320,692
327,177
333,004
334,589
341,406
349,983
356,463
386,788
413,776
401,682
411,656
412,016
424,122
433,925
432,014
747,835
761,833
774,149
786,637
793,388
809,723
826,705
839,740
843,004
857,745
878,095
893,934
895,374
913,298
930,243
946,919
949,395
981,655
989,249
1,009,108
1,012,168
1,047,734
1,071,556
1,097,351
1,096,107
1,127,890
1,158,113
1,188,841
1,188,826
1,222,419
1,266,624
1,298,605
1,283,500
1,308,218
1,354,189
1,354,1891,308,2181,283,5001,298,6051,266,6241,222,4191,188,8261,188,8411,158,1131,127,8901,096,1071,097,3511,071,5561,047,7341,012,1681,009,108989,249981,655949,395946,919930,243913,298895,374893,934878,095857,745843,004839,740826,705809,723793,388786,637774,149761,833747,835432,014433,925424,122412,016411,656401,682413,776386,788356,463349,983341,406334,589333,004327,177320,692314,002312,757308,519304,478298,746297,094293,138289,179284,335283,930280,223277,311274,124270,288267,121264,221261,917262,700257,351255,331253,475255,000253,933252,725251,169251,755249,762251,733251,376248,247245,504241,263236,94485,26069,48455,159
   Common Stock
40,000
40,000
40,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
60,000
90,000
90,000
90,000
90,000
90,000
90,000
90,000
90,000
117,000
117,000
117,000
117,000
117,000
117,000
117,000
117,000
152,100
152,100
152,100
152,100
156,700
156,700
156,700
156,700
156,700
156,700
156,700
156,700
168,909
168,909
168,909
168,909
168,909
219,582
219,582
219,582
285,456
285,456
285,456
285,456
285,456
285,456
285,456
285,456
285,456
288,105
288,105
287,990
287,990
287,990
287,990
287,990
287,990
287,990
287,990
287,990
287,146
287,146
287,146
287,146
287,146
0
0
00287,146287,146287,146287,146287,146287,990287,990287,990287,990287,990287,990287,990287,990287,990288,105288,105285,456285,456285,456285,456285,456285,456285,456285,456285,456219,582219,582219,582168,909168,909168,909168,909168,909156,700156,700156,700156,700156,700156,700156,700156,700152,100152,100152,100152,100117,000117,000117,000117,000117,000117,000117,000117,00090,00090,00090,00090,00090,00090,00090,00090,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00060,00040,00040,00040,000
   Retained Earnings 
4,355
13,953
27,363
30,051
34,370
33,924
36,667
42,786
43,153
40,093
39,086
41,500
43,056
43,529
0
44,687
46,543
47,819
52,762
51,888
54,192
55,882
59,049
62,886
66,072
67,685
71,392
71,797
76,642
78,527
82,483
84,179
89,911
92,388
96,626
97,871
104,561
108,615
114,443
116,027
122,844
128,571
135,051
132,450
143,694
136,943
172,130
172,490
184,596
194,399
192,488
204,880
218,878
231,194
243,681
250,433
266,768
283,750
296,785
300,322
315,062
335,413
351,252
352,691
370,615
387,560
356,712
359,138
379,582
445,025
464,162
465,936
500,304
523,836
549,261
547,116
578,692
611,573
641,982
641,336
674,967
717,050
748,170
735,506
679,119
712,265
712,265679,119735,506748,170717,050674,967641,336641,982611,573578,692547,116549,261523,836500,304465,936464,162445,025379,582359,138356,712387,560370,615352,691351,252335,413315,062300,322296,785283,750266,768250,433243,681231,194218,878204,880192,488194,399184,596172,490172,130136,943143,694132,450135,051128,571122,844116,027114,443108,615104,56197,87196,62692,38889,91184,17982,48378,52776,64271,79771,39267,68566,07262,88659,04955,88254,19251,88852,76247,81946,54344,687043,52943,05641,50039,08640,09343,15342,78636,66733,92434,37030,05127,36313,9534,355
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
266,819
0
0
0
0
0
00000266,81900000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,174,100
Cost of Revenue-1,127,547
Gross Profit1,046,5541,046,554
 
Operating Income (+$)
Gross Profit1,046,554
Operating Expense-1,975,664
Operating Income198,436-929,110
 
Operating Expense (+$)
Research Development132,141
Selling General Administrative610,355
Selling And Marketing Expenses0
Operating Expense1,975,664742,496
 
Net Interest Income (+$)
Interest Income1,331
Interest Expense-26,688
Other Finance Cost-351
Net Interest Income-25,708
 
Pretax Income (+$)
Operating Income198,436
Net Interest Income-25,708
Other Non-Operating Income Expenses0
Income Before Tax (EBT)175,032198,436
EBIT - interestExpense = -26,688
135,009
161,697
Interest Expense26,688
Earnings Before Interest and Taxes (EBIT)0201,720
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax175,032
Tax Provision-23,692
Net Income From Continuing Ops151,340151,340
Net Income135,009
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net025,708
 

Technical Analysis of Jiangsu Lianhuan Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Lianhuan Pharmaceutical Co Ltd. The general trend of Jiangsu Lianhuan Pharmaceutical Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Lianhuan Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Lianhuan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.8 < 9.36 < 9.65.

The bearish price targets are: 6.71.

Tweet this
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current macd is -0.12849015.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Lianhuan Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jiangsu Lianhuan Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jiangsu Lianhuan Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current adx is 17.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jiangsu Lianhuan Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current sar is 9.12.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current rsi is 42.55. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Lianhuan Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current cci is -184.95460441.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current cmo is -18.12673794.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current willr is -62.6984127.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jiangsu Lianhuan Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Williams %R ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Lianhuan Pharmaceutical Co Ltd.

Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current atr is 0.32927128.

Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current obv is 151,668,883.

Jiangsu Lianhuan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Lianhuan Pharmaceutical Co Ltd. The current mfi is 39.96.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Lianhuan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Lianhuan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Jiangsu Lianhuan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Lianhuan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.548
Ma 20Greater thanMa 509.038
Ma 50Greater thanMa 1008.803
Ma 100Greater thanMa 20010.038
OpenGreater thanClose8.190
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Jiangsu Lianhuan Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Lianhuan Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Lianhuan Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Lianhuan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Jiangsu Lianhuan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Lianhuan Pharmaceutical Co Ltd.

Receive notifications about Jiangsu Lianhuan Pharmaceutical Co Ltd in your mailbox!